Hikma Hikes Generics Guidance As It Prepares For New CEO

Also Picks Up US Injectables Assets From Akorn In The Wake Of Bankruptcy

 
• By David Wallace
  
Businessman drawing graph upwards
Hikma is improving its expectations for its generics business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business